|
|
|
| Advancesin research on the relationship between human papilloma-virus infection and genital lesions |
| ZHANG Shihua SUN Hui DU Yandan▲ |
| Department of Laboratory, Inner Mongolia Forestry General Hospital the Second Clinical Medicine College of Inner Mongolia University for Nationalities, Inner Mongolia Autonomous Region, Yakeshi 022150, China |
|
|
|
Abstract Human papillomavirus (HPV) can be divided into high-risk type and low-risk type according to pathogenicity. The high-risk type mainly causes cervical cancer in women and the penis cancer in men, while the low-risk type mainly causes genital warts. Different genotypes cause certain differences in disease types. HPV-16 is the main type of female squamous cell carcinoma; HPV-18 is the main type of female adenocarcinoma and adenosquamous carcinoma; HPV-16 and HPV-18 infection are the main types of male penile cancer; the main types of female genital warts and male genital warts and infertility are HPV-6 and HPV-11. Currently, there are two preventive and therapeutic vaccines for HPV on the market. Different populations should choose vaccines in a targeted and reasonable manner, which is essential for preventing and eliminating HPV.
|
|
|
|
|
|
[1] Chan PKS，Cheung JLK，Cheung TH，et al. Profile of viral load，integration，and E2 gene disruption of HPV58 in normal cervix and cervical neoplasia [J]. J Infect Dis，2007， 196（6）：868-875.
[2] Torre LA，Siegel RL，Ward EM，et al. Global cancer incidence and mortality rates and trends—an update [J]. Cancer Epidemiol Biomarkers Prev，2016，25（1）：16-27.
[3] Van Bilsen WPH，Kovaleva A，Bleeker MCG，et al. HPV infections and flat penile lesions of the penis in men who have sex with men [J]. Papillomavirus Res，2019，8：100173.
[4] Le HHL，Bi X，Ishizaki A，et al. Low concordance of oral and genital HPV infection among male patients with sexually transmitted infections in Vietnam [J]. BMC Infect Dis，2019，19（1）：578.
[5] Wu J，Li X，Liu X，et al. Human papillomavirus genotype prevalence in the women of Shanghai，China and its association with the severity of cervical neoplasia [J]. Int J Clin Exp，2018，11（9）：4614-4621.
[6] White EA，Münger K，Howley PM. High-Risk Human Papillomavirus E7 Proteins Target PTPN14 for Degradation [J]. MBio，2016，7（5）：e01530-16.
[7] Budenz A，Klassen A，Leader A，et al. HPV vaccine，Twitter，and gay，bisexual and other men who have sex with men [J]. Health Promotion Int，2019，pii：daz030.
[8] Hoory T，Monie A，Gravitt P，et al. Molecular epidemiology of human papillomavirus [J]. J Formos Med Assoc，2008， 107（3）：198-217.
[9] de Sanjosé S，Serrano B，Tous S，et al. Burden of Human Papillomavirus （HPV）-Related Cancers Attributable to HPVs 6/11/16/18/31/33/45/52 and 58 [J]. JNCI Cancer Spectr，2019，2（4）：pky045.
[10] Chin-Hong PV，Reid GE，AST Infectious Diseases Community of Practice. Human papillomavirus infection in solid organ transplant recipients：Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice [J]. Clin Transplant，2019，33（9）：e13590.
[11] zur Hausen H. Papillomaviruses and cancer：from basic studies to clinical application [J]. Nat Rev Cancer，2002， 2（5）：342-350.
[12] Nair S，Pillai MR. Human papillomavirus and disease mechanisms：relevance to oral and cervical cancers [J]. Oral Dis，2005，11（6）：350-359.
[13] Almeida AM，Queiroz JA，Sousa F，et al. Cervical cancer and HPV infection：ongoing therapeutic research to counteract the action of E6 and E7 oncoproteins [J]. Drug Discov Today，2019，24（10）：2044-2057.
[14] 施启丰，崔成军，王昊珏，等.华东地区宫颈鳞状细胞癌组织HPV感染型别的特征分析[J].贵州医药，2019，43（8）：1320-1322.
[15] 吴斌，于晓红.HPV与宫颈腺癌研究进展[J].江西医药，2015，50（2）：180-182.
[16] Kurman RJ，Carcangiu ML，Herrington CS，et al. WHO classification of tumors of female reproductive organs [M]. Lyon：International Agency for Research on Cancer，2014：176-178.
[17] 王志强，金玉兰.宫颈腺癌及前驱病变与HPV的关系研究进展[J].中国医刊，2018，53（11）：1219-1222.
[18] Castellsagué X，Díaz M，De Sanjosé S，et al. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors：implications for screening and prevention [J]. J Natl Cancer Inst，2006，98（5）：303-315.
[19] Boeri L，Capogrosso P，Ventimiglia E，et al. High-risk human papillomavirus in semen is associated with poor sperm progressive motility and a high sperm DNA fragmentation index in infertile men [J]. Hum Reprod，2018， 34（2）：209-217.
[20] Smith JS，Gilbert PA，Melendy A，et al. Age-specific prevalence of human papillomavirus infection in males：a global review [J]. J Adolesc Health，2011，48（6）：540-552.
[21] Giuliano AR，Lu B，Nielson CM，et al. Age-specific prevalence，incidence，and duration of human papillomavirus infections in a cohort of 290 US men [J]. J Infect Dis，2008，198（6）：827-835.
[22] Partridge JM，Hughes JP，Feng Q，et al. Genital human papillomavirus infection in men：incidence and risk factors in a cohort of university students [J]. J Infect Dis，2007，196（8）：1128-1136.
[23] Garolla A，De Toni L，Bottacin A，et al. Human Papillomavirus Prophylactic Vaccination improves reproductive outcome in infertile patients with HPV semen infection：a retrospective study [J]. Sci Rep，2018，8（1）：912.
[24] Sun YF，Yang XR，Zhou J，et al. Circulating tumor cells：advances in detection methods，biological issues，and clinical relevance [J]. J Cancer Res Clin Oncol，2011， 137（8）：1151-1173.
[25] 吕兴，马兰芳，杨书红.男性HPV感染的流行病学研究进展[J].现代预防医学，2015，42（15）：2701-2703，2708.
[26] Scheiner MA，Campos MM，Ornellas AA，et al. Human papillomavirus and penile cancers in Rio de Janeiro，Brazil：HPV typing and clinical features [J]. Int Braz J Urol，2008，34（4）：467-476.
[27] Backes DM，Kurman RJ，Pimenta JM，et al. Systematic review of human papillomavirus prevalence in invasive penile cancer [J]. Cancer Causes Control，2009，20（4）：449-457.
[28] Norman I. Human papillomavirus and cervical cancer：detection of potential markers of disease progression using liquid-based cytology [M]. Huddinge：Karolinska Institutet，2015.
[29] Lee IH，Park JB，Cheong M，et al. Antitumor therapeutic and antimetastatic activity of electroporation-delivered human papillomavirus 16 E7 DNA vaccines：a possible mechanism for enhanced tumor control [J]. DNA Cell Biol，2011，30（12）：975-985. |
|
|
|
